Welcome to LookChem.com Sign In|Join Free

CAS

  • or

959640-90-5

Post Buying Request

959640-90-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

959640-90-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 959640-90-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,6,4 and 0 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 959640-90:
(8*9)+(7*5)+(6*9)+(5*6)+(4*4)+(3*0)+(2*9)+(1*0)=225
225 % 10 = 5
So 959640-90-5 is a valid CAS Registry Number.

959640-90-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,8-Diazaspiro[4.5]decane, 8-cyclobutyl-

1.2 Other means of identification

Product number -
Other names 8-cyanotetrazolo<1,5-a>pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:959640-90-5 SDS

959640-90-5Downstream Products

959640-90-5Relevant articles and documents

SUBSTITUTED AZASPIRO DERIVATIVES

-

Page/Page column 36, (2008/12/08)

Substituted azaspiro derivatives of the Formula:are provided, in which variables are as described herein. Such compounds may be used to modulate ligand binding to histamine H3 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of central nervous system (CNS) and other disorders in humans, domesticated companion animals and livestock animals. Compounds provided herein may be administered alone or in combination with one or more other CNS agents to potentiate the effects of the other CNS agent(s). Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such ligands for detecting histamine H3 receptors (e.g., receptor localization studies).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 959640-90-5